Contineum Therapeutics, Inc. (CTNM) stock
CTNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30
$9.24−0.31 (-3.25%)
Close on Nov 18, 2026Market cap $347.62MP/E –Yield –
Contineum Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Contineum Therapeutics's price to book ratio was 1.5× on Nov 11, 2026, against 1.6× a year earlier. Over the last 2 years it ranged from 0.4× to 2.3×, with a median of 1.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.5× | −0.2 |
| 2025 | Dec 31, 2025 | 1.7× | +0.7 |
| 2024 | Dec 31, 2024 | 1.0× | – |
See a number that looks wrong?